www.xinhuanet.com
XINHUA online
CHINA VIEW
VIEW CHINA
 Breaking News Urgent: Iraqi Governing Council submits timetable for constitutional convention     Urgent: Jury recommends death sentence for Washington sniper     Urgent: Bush signs 401-billion-dollar defense authorization bill     Urgent: Shevardnadze remains in Tbilisi: official     Urgent: UK, France agree EU defense must be consistent with NATO     Iraq's interim authority shuts down Al-Arabiya Baghdad office    
Home  
China  
World  
Business  
Technology  
Opinion  
Culture/Edu  
Sports  
Entertainment  
Metrolife  
Travel  
Weather  
  About China
  Map
  History
  Constitution
  CPC & Other Parties
  State Organs
  Local Leadership
  White Papers
  Statistics
  Major Projects
  English Websites
  BizChina
- Conferences & Exhibitions
- Investment
- Bidding
- Enterprises
- Policy update
- Technological & Economic Development Zones

   News Photos Voice People BizChina Feature About us   
First applicant for SARS vaccine test in Guangzhou
www.chinaview.cn 2003-11-25 08:12:03

Guangzhou, Nov. 25, (Xinhuanet) -- A Retired woman has offered to test a SARS vaccine developed in Guangdong.

Ms. Tao, 50, was the first applicant for the test in the province, the Guangzhou Daily reported.

Tao, who lives in Shunde District, Foshan, said she had not contracted SARS this year. However, she deeply sympathized with her colleagues and neighbors who contracted the virus.

Guangdong began to recruit volunteers to test the SARS vaccine starting from Monday. Many people had applied for the test since the news was released.

The vaccine had passed a trial on animals and would go on clinical trial if found to be successful on volunteers, said a SARS expert.

The volunteers would be chosen from different age groups, but most should be young people, experts said. Volunteers should have no SARS history, they said.

About 200 volunteers were needed for the first stage of the tests, while the third stage would need more than 1,000 volunteers, said an expert with the provincial disease control and prevention center.

The efficacy of the vaccine would not be known until it could be tested on a SARS patient, said the expert.

The vaccine is now being examined by the State Food and Drug Administration. It was submitted to the administration at the same time a SARS vaccine developed by the Beijing Kexing Bio-product Co. was submitted.

The expert said he felt confident that enough volunteers would be recruited. Enditem

(Shenzhen Daily)

  Related Story
Copyright ©2003 Xinhua News Agency. All rights reserved.
Reproduction in whole or in part without permission is prohibited.